Skip to main content
Top
Published in: Inflammation 1/2019

01-02-2019 | ORIGINAL ARTICLE

MerTK Downregulates Lipopolysaccharide-Induced Inflammation Through SOCS1 Protein but Does Not Affect Phagocytosis of Escherichia coli in Macrophages

Authors: Bing Zhang, HuiYu Lu, AiGui Jiang, HuiMei Wu, Lei Fang, YuXin Lv

Published in: Inflammation | Issue 1/2019

Login to get access

Abstract

Bacterial lipopolysaccharide (LPS) induces inflammatory response via toll-like receptor 4 (TLR4). However, this response must be strictly regulated because unbalanced overproduction of pro-inflammatory cytokines can lead to tissue damage and even be fatal. Herein, we explore whether Mer receptor tyrosine kinase (MerTK) regulates Escherichia coli (E. coli) LPS-induced inflammation and mediates phagocytosis of E. coli by macrophages. The results showed that LPS activated TLR4 signaling pathway and induced MerTK pathway in RAW264.7 macrophages, including suppressor of cytokine signaling1 (SOCS1). Preincubation with MerTK-specific blocking antibody (MerTK-Ab) markedly suppressed LPS-induced expression of phosphorylated MerTK, while further promoted LPS-induced production of TNF-α, IL-6, and IL-1β as well as phosphorylation of IκB-α and p65. Likewise, MerTK-Ab prevented LPS-induced SOCS1 expression. Furthermore, LPS-induced production of pro-inflammatory cytokines and activation of NF-κB were increased by transfection with SOCS1 siRNA. Additionally, we demonstrated that MerTK was dispensable in phagocytosis of E. coli by RAW264.7 or peritoneal macrophages. Collectively, these results indicate that MerTK downregulates LPS-induced inflammation through SOCS1 protein without affecting phagocytosis of E. coli in macrophages.
Literature
1.
go back to reference Galli, S.J., M. Grimbaldeston, and M. Tsai. 2008. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nature Reviews. Immunology 8: 478–486.CrossRefPubMedPubMedCentral Galli, S.J., M. Grimbaldeston, and M. Tsai. 2008. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nature Reviews. Immunology 8: 478–486.CrossRefPubMedPubMedCentral
2.
go back to reference Ma, W., Y. Dumont, F. Vercauteren, and R. Quirion. 2010. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology 130: 399–409.CrossRefPubMedPubMedCentral Ma, W., Y. Dumont, F. Vercauteren, and R. Quirion. 2010. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology 130: 399–409.CrossRefPubMedPubMedCentral
3.
go back to reference Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nature Reviews. Immunology 1: 135–145.CrossRefPubMed Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nature Reviews. Immunology 1: 135–145.CrossRefPubMed
4.
go back to reference Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. International Immunology 17: 1–14.CrossRefPubMed Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. International Immunology 17: 1–14.CrossRefPubMed
5.
go back to reference Seeley, J.J., and S. Ghosh. 2017. Molecular mechanisms of innate memory and tolerance to LPS. Journal of Leukocyte Biology 101: 107–119.CrossRefPubMed Seeley, J.J., and S. Ghosh. 2017. Molecular mechanisms of innate memory and tolerance to LPS. Journal of Leukocyte Biology 101: 107–119.CrossRefPubMed
6.
go back to reference Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583–591.CrossRefPubMed Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583–591.CrossRefPubMed
7.
go back to reference Zielen, S., J. Trischler, and R. Schubert. 2015. Lipopolysaccharide challenge: immunological effects and safety in humans. Expert Review of Clinical Immunology 11: 409–418.CrossRefPubMed Zielen, S., J. Trischler, and R. Schubert. 2015. Lipopolysaccharide challenge: immunological effects and safety in humans. Expert Review of Clinical Immunology 11: 409–418.CrossRefPubMed
8.
go back to reference Liew, F.Y., D. Xu, E.K. Brint, and L.A.J. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nature Reviews. Immunology 5: 446–458.CrossRefPubMed Liew, F.Y., D. Xu, E.K. Brint, and L.A.J. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nature Reviews. Immunology 5: 446–458.CrossRefPubMed
9.
go back to reference Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.CrossRefPubMed Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.CrossRefPubMed
10.
go back to reference Rothlin, C.V., S. Ghosh, E.I. Zuniga, M.B.A. Oldstone, and G. Lemke. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124–1136.CrossRefPubMed Rothlin, C.V., S. Ghosh, E.I. Zuniga, M.B.A. Oldstone, and G. Lemke. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124–1136.CrossRefPubMed
11.
go back to reference Williams, J.C., R.R. Craven, H.S. Earp, et al. 2009. TAM receptors are dispensable in the phagocytosis and killing of bacteria. Cellular Immunology 259: 128–134.CrossRefPubMedPubMedCentral Williams, J.C., R.R. Craven, H.S. Earp, et al. 2009. TAM receptors are dispensable in the phagocytosis and killing of bacteria. Cellular Immunology 259: 128–134.CrossRefPubMedPubMedCentral
12.
go back to reference Tan, Y., and J.C. Kagan. 2014. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Molecular Cell 54: 212–223.CrossRefPubMedPubMedCentral Tan, Y., and J.C. Kagan. 2014. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Molecular Cell 54: 212–223.CrossRefPubMedPubMedCentral
13.
go back to reference Behrens, E.M., P. Gadue, S.Y. Gong, et al. 2003. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. European Journal of Immunology 33: 2160–2167.CrossRefPubMed Behrens, E.M., P. Gadue, S.Y. Gong, et al. 2003. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. European Journal of Immunology 33: 2160–2167.CrossRefPubMed
14.
go back to reference Camenisch, T.D., B.H. Koller, H.S. Earp, et al. 1999. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. Journal of Immunology 162: 3498–3503. Camenisch, T.D., B.H. Koller, H.S. Earp, et al. 1999. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. Journal of Immunology 162: 3498–3503.
15.
go back to reference Scott, R.S., E.J. McMahon, S.M. Pop, E.A. Reap, R. Caricchio, P.L. Cohen, H.S. Earp, and G.K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207–211.CrossRefPubMed Scott, R.S., E.J. McMahon, S.M. Pop, E.A. Reap, R. Caricchio, P.L. Cohen, H.S. Earp, and G.K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207–211.CrossRefPubMed
16.
go back to reference Seitz, H.M., T.D. Camenisch, G. Lemke, H.S. Earp, and G.K. Matsushima. 2007. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. Journal of Immunology 178: 5635–5642.CrossRef Seitz, H.M., T.D. Camenisch, G. Lemke, H.S. Earp, and G.K. Matsushima. 2007. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. Journal of Immunology 178: 5635–5642.CrossRef
17.
go back to reference Lu, Q., and G. Lemke. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306–311.CrossRefPubMed Lu, Q., and G. Lemke. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306–311.CrossRefPubMed
18.
go back to reference Wu, H.M., J. Wang, B. Zhang, et al. 2016. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage. Life Sciences 161: 51–59.CrossRefPubMed Wu, H.M., J. Wang, B. Zhang, et al. 2016. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage. Life Sciences 161: 51–59.CrossRefPubMed
19.
go back to reference Sen, P., M.A. Wallet, Z. Yi, Y. Huang, M. Henderson, C.E. Mathews, H.S. Earp, G. Matsushima, A.S. Baldwin, and R.M. Tisch. 2007. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109: 653–660.CrossRefPubMedPubMedCentral Sen, P., M.A. Wallet, Z. Yi, Y. Huang, M. Henderson, C.E. Mathews, H.S. Earp, G. Matsushima, A.S. Baldwin, and R.M. Tisch. 2007. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109: 653–660.CrossRefPubMedPubMedCentral
20.
go back to reference Alciato, F., P.P. Sainaghi, D. Sola, L. Castello, and G.C. Avanzi. 2010. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. Journal of Leukocyte Biology 87: 869–875.CrossRefPubMed Alciato, F., P.P. Sainaghi, D. Sola, L. Castello, and G.C. Avanzi. 2010. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. Journal of Leukocyte Biology 87: 869–875.CrossRefPubMed
21.
go back to reference Anwar, A., A.K. Keating, D. Joung, S. Sather, G.K. Kim, K.K. Sawczyn, L. Brandão, P.M. Henson, and D.K. Graham. 2009. Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress. Journal of Leukocyte Biology 86: 73–79.CrossRefPubMedPubMedCentral Anwar, A., A.K. Keating, D. Joung, S. Sather, G.K. Kim, K.K. Sawczyn, L. Brandão, P.M. Henson, and D.K. Graham. 2009. Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress. Journal of Leukocyte Biology 86: 73–79.CrossRefPubMedPubMedCentral
22.
go back to reference Park, H.J., J.Y. Baen, Y.J. Lee, Y.H. Choi, and J.L. Kang. 2012. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells. Molecular Biology of the Cell 23: 3254–3265.CrossRefPubMedPubMedCentral Park, H.J., J.Y. Baen, Y.J. Lee, Y.H. Choi, and J.L. Kang. 2012. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells. Molecular Biology of the Cell 23: 3254–3265.CrossRefPubMedPubMedCentral
23.
go back to reference Wallet, M.A., P. Sen, R.R. Flores, Y. Wang, Z. Yi, Y. Huang, C.E. Mathews, H.S. Earp, G. Matsushima, B. Wang, and R. Tisch. 2008. MerTK is required for apoptotic cell-induced T cell tolerance. The Journal of Experimental Medicine 205: 219–232.CrossRefPubMedPubMedCentral Wallet, M.A., P. Sen, R.R. Flores, Y. Wang, Z. Yi, Y. Huang, C.E. Mathews, H.S. Earp, G. Matsushima, B. Wang, and R. Tisch. 2008. MerTK is required for apoptotic cell-induced T cell tolerance. The Journal of Experimental Medicine 205: 219–232.CrossRefPubMedPubMedCentral
24.
go back to reference Lee, Y.J., J.Y. Han, J. Byun, H.J. Park, E.M. Park, Y.H. Chong, M.S. Cho, and J.L. Kang. 2012. Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-kappaB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury. Journal of Leukocyte Biology 91: 921–932.CrossRefPubMed Lee, Y.J., J.Y. Han, J. Byun, H.J. Park, E.M. Park, Y.H. Chong, M.S. Cho, and J.L. Kang. 2012. Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-kappaB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury. Journal of Leukocyte Biology 91: 921–932.CrossRefPubMed
25.
go back to reference Guha, M., and N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. The Journal of Biological Chemistry 277: 32124–32132.CrossRefPubMed Guha, M., and N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. The Journal of Biological Chemistry 277: 32124–32132.CrossRefPubMed
26.
go back to reference Graham, B., and S.B. Gibson. 2005. The two faces of NFkappaB in cell survival responses. Cell Cycle 4: 1342–1345.CrossRefPubMed Graham, B., and S.B. Gibson. 2005. The two faces of NFkappaB in cell survival responses. Cell Cycle 4: 1342–1345.CrossRefPubMed
27.
go back to reference Zhang, B., H. Wu, L. Fang, P. Ding, K. Xu, Q. Yang, and R. Liu. 2017. MerTK does not mediate phagocytosis of Staphylococcus aureus but attenuates inflammation induced by staphylococcal lipoteichoic acid through blocking NF-κB activation. Inflammation 40: 1543–1552.CrossRefPubMed Zhang, B., H. Wu, L. Fang, P. Ding, K. Xu, Q. Yang, and R. Liu. 2017. MerTK does not mediate phagocytosis of Staphylococcus aureus but attenuates inflammation induced by staphylococcal lipoteichoic acid through blocking NF-κB activation. Inflammation 40: 1543–1552.CrossRefPubMed
28.
go back to reference Dalpke, A.H., S. Opper, S. Zimmermann, and K. Heeg. 2001. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. Journal of Immunology 166: 7082–7089.CrossRef Dalpke, A.H., S. Opper, S. Zimmermann, and K. Heeg. 2001. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. Journal of Immunology 166: 7082–7089.CrossRef
29.
go back to reference Mansell, A., R. Smith, S.L. Doyle, P. Gray, J.E. Fenner, P.J. Crack, S.E. Nicholson, D.J. Hilton, L.A.J. O'Neill, and P.J. Hertzog. 2006. Suppressor of cytokine signaling 1 negatively regulates toll-like receptor signaling by mediating Mal degradation. Nature Immunology 7: 148–155.CrossRefPubMed Mansell, A., R. Smith, S.L. Doyle, P. Gray, J.E. Fenner, P.J. Crack, S.E. Nicholson, D.J. Hilton, L.A.J. O'Neill, and P.J. Hertzog. 2006. Suppressor of cytokine signaling 1 negatively regulates toll-like receptor signaling by mediating Mal degradation. Nature Immunology 7: 148–155.CrossRefPubMed
30.
go back to reference Zheng, J., P. Yang, Y. Tang, et al. 2015. Respiratory syncytial virus nonstructural proteins upregulate SOCS1 and SOCS3 in the different manner from endogenous IFN signaling. Journal of Immunology Research 2015: 738547.CrossRefPubMedPubMedCentral Zheng, J., P. Yang, Y. Tang, et al. 2015. Respiratory syncytial virus nonstructural proteins upregulate SOCS1 and SOCS3 in the different manner from endogenous IFN signaling. Journal of Immunology Research 2015: 738547.CrossRefPubMedPubMedCentral
31.
go back to reference Wu, Y., N. Tibrewal, and R.B. Birge. 2006. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends in Cell Biology 16: 189–197.CrossRefPubMed Wu, Y., N. Tibrewal, and R.B. Birge. 2006. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends in Cell Biology 16: 189–197.CrossRefPubMed
33.
go back to reference Mark, M.R., J. Chen, R.G. Hammonds, M. Sadick, and P.J. Godowsk. 1996. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. The Journal of Biological Chemistry 271: 9785–9789.CrossRefPubMed Mark, M.R., J. Chen, R.G. Hammonds, M. Sadick, and P.J. Godowsk. 1996. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. The Journal of Biological Chemistry 271: 9785–9789.CrossRefPubMed
Metadata
Title
MerTK Downregulates Lipopolysaccharide-Induced Inflammation Through SOCS1 Protein but Does Not Affect Phagocytosis of Escherichia coli in Macrophages
Authors
Bing Zhang
HuiYu Lu
AiGui Jiang
HuiMei Wu
Lei Fang
YuXin Lv
Publication date
01-02-2019
Publisher
Springer US
Published in
Inflammation / Issue 1/2019
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0877-5

Other articles of this Issue 1/2019

Inflammation 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.